MCT4 Expression in Pancreatic Cancer: Association with Prognosis, and Potential for Targeting Cancer Metabolism

被引：0
|
作者：
McFalls, J.
Buboltz, N. D.
Knudsen, E.
Witkiewicz, A.
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1783
引用
收藏
页码：428A / 428A
页数：1
相关论文
共 50 条
  • [21] Expression of MCT1 and MCT4 in a patient with mitochondrial myopathy
    Baker, SK
    Tarnopolsky, MA
    Bonen, A
    MUSCLE & NERVE, 2001, 24 (03) : 394 - 398
  • [22] Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
    Dell'Anno, Irene
    Barone, Elisa
    Mutti, Luciano
    Rassl, Doris M.
    Marciniak, Stefan J.
    Silvestri, Roberto
    Landi, Stefano
    Gemignani, Federica
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [23] THE USE OF MCT1 AND MCT4 AS ENDOGENOUS HYPOXIA MARKERS IN COLORECTAL CANCER.
    Debucquoy, A.
    Khan, N. A.
    Sagaert, X.
    Penninckx, F.
    Begg, A.
    Haustermans, K.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S613 - S614
  • [24] Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells
    Hu, Xiao
    Liu, Zhanzhao
    Duan, Xianxian
    Han, Xiao
    Yuan, Mengci
    Liu, Lingyan
    Xia, Xiaojun
    Li, Ning
    Qin, Junfang
    Wang, Yue
    MOLECULAR CARCINOGENESIS, 2021, 60 (10) : 702 - 714
  • [25] Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
    Irene Dell’Anno
    Elisa Barone
    Luciano Mutti
    Doris M. Rassl
    Stefan J. Marciniak
    Roberto Silvestri
    Stefano Landi
    Federica Gemignani
    Journal of Translational Medicine, 18
  • [26] Therapeutic potential of targeting amino acid metabolism in pancreatic cancer
    Fernandez-Zapico, Martin
    Kim, Dae Won
    Philip, Philip
    Vandell, Alexander
    Eckard, Jonathan
    Korn, Ron
    Del Priore, Giuseppe
    Simeone, Diane
    CANCER RESEARCH, 2019, 79 (24)
  • [27] Decoding and targeting of metabolic heterogeneity in pancreatic neuroendocrine tumors (PanNETs): MCT1 and MCT4 in the crosshair for precision therapy
    Brautigam, K.
    Straub, J.
    Bihi, A.
    Andreasi, V
    Kirchner, P.
    Dettmer, M.
    Schrader, J.
    Partelli, S.
    Falconi, M.
    Marinoni, I
    Sadowski, M.
    Perren, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 48 - 48
  • [28] MCT4 Defines a Metabolic Subtype of PDA with Poor Prognosis and Provides Potential Therapeutic Target
    Wachsmann, M.
    Tse, Y.
    Franco, J.
    Knudsen, E.
    Witkiewicz, A.
    LABORATORY INVESTIGATION, 2014, 94 : 456A - 457A
  • [29] MCT4 Defines a Metabolic Subtype of PDA with Poor Prognosis and Provides Potential Therapeutic Target
    Wachsmann, M.
    Tse, Y.
    Franco, J.
    Knudsen, E.
    Witkiewicz, A.
    MODERN PATHOLOGY, 2014, 27 : 456A - 457A
  • [30] Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
    Zhao, Yang
    Zhao, Bin
    Yan, Wei-Hua
    Xia, Yan
    Wang, Zhi-Hui
    Zheng, Guo-Yang
    Wang, Wen-Da
    Zhang, Yu-Shi
    FRONTIERS IN ONCOLOGY, 2021, 11
12345